- Investing Ideas
- /
- Global Fast Growing Stocks With High Insider Ownership
Global Fast Growing Stocks With High Insider Ownership
Results
1469
0 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,469 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ACI | ₹712.05 | -7.7% | 37.0% | ₹87.9b | ₹832.17 | PE32.5x | E35.0% | 0.4% | Materials | ||
A178320 | ₩26,950.00 | 6.3% | 73.9% | ₩1.5t | ₩39,333.33 | PE140.3x | E58.7% | 0% | Tech | ||
505283 | ₹1,264.25 | -8.5% | 96.6% | ₹81.9b | ₹1,706.50 | PE57.6x | E30.1% | 0.5% | Capital Goods | ||
VOW | NOK 7.02 | 1.0% | -52.5% | NOK 799.2m | NOK 11.00 | PB2x | E97.7% | 0% | Commercial Services | ||
4480 | JP¥3,510.00 | -3.8% | -27.3% | JP¥113.9b | JP¥5,800.00 | PE42.6x | E28.7% | n/a | Healthcare | ||
CTT | AU$1.12 | -14.5% | -66.2% | AU$457.8m | AU$3.12 | PE22.1x | E26.7% | n/a | Retail | ||
CALTX | SEK 206.40 | 0.1% | 94.7% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YGG | ฿1.24 | -5.3% | -83.7% | ฿746.5m | ฿10.75 | PE10.8x | E33.5% | 21.6% | Media | ||
688408 | CN¥60.26 | 0.7% | 34.4% | CN¥12.1b | CN¥66.22 | PE26.3x | E28.4% | 1.0% | Capital Goods | ||
A179900 | ₩27,800.00 | -6.4% | 47.5% | ₩439.8b | ₩60,000.00 | PS21.9x | E122.7% | 0% | Tech | ||
PLT | AU$0.70 | -2.8% | 81.8% | AU$122.7m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
A137400 | ₩56,200.00 | 7.0% | -21.2% | ₩1.3t | ₩86,850.00 | PE15x | E35.0% | 0% | Capital Goods | ||
A067310 | ₩15,000.00 | -10.1% | -6.8% | ₩818.1b | ₩24,347.83 | PB2.8x | E97.4% | 0.3% | Semiconductors | ||
KEBNI B | SEK 1.49 | 5.4% | 3.6% | SEK 405.1m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
GIG | NOK 29.55 | -0.2% | 6.7% | NOK 4.0b | NOK 45.03 | PE18.4x | E37.4% | n/a | Consumer Services | ||
CUV | AU$14.05 | -4.3% | -29.3% | AU$703.6m | AU$30.33 | PE23.3x | E26.8% | 0.4% | Pharmaceuticals & Biotech | ||
AV1 | AU$0.06 | -4.8% | 33.3% | AU$47.3m | n/a | PS14.6x | E103.9% | n/a | Software | ||
CRDO | US$27.47 | 8.4% | 91.7% | US$4.5b | US$32.17 | PS23.5x | E60.9% | n/a | Semiconductors | ||
LAVV3 | R$8.60 | -4.7% | -3.4% | R$1.7b | R$12.90 | PE6.2x | E21.2% | 3.3% | Real Estate Management and Development | ||
ADOC | €5.73 | 1.8% | -7.4% | €86.2m | €6.30 | PS14.2x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
A441270 | ₩7,440.00 | -5.1% | -10.6% | ₩275.1b | ₩11,500.00 | PE17.7x | E36.4% | n/a | Tech | ||
A204620 | ₩4,100.00 | 7.3% | -12.8% | ₩232.8b | ₩7,233.33 | PS2.2x | E90.6% | n/a | Commercial Services | ||
EH | US$12.74 | 7.4% | -37.7% | US$806.3m | US$24.98 | PS36.8x | E74.3% | n/a | Capital Goods | ||
HQU | S$0.46 | 1.1% | 95.7% | S$65.8m | n/a | PE11.5x | E21.1% | 3.6% | Capital Goods |